Company
Headquarters: Dammam, Saudi Arabia
CEO: Mr. Nasser Sultan Al-Hammad Al-Subaie
SR23.36 Billion
SAR as of Jan. 1, 2024
US$6.23 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Mouwasat Medical Services Company acquires, manages, operates, and maintains hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. It operates a network of hospitals in Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh that provides a range of medical services. The company also operates skin care centers, which offer laser, cosmetic dermatological, reconstructive surgery, beauty, clinical dermatology, plastic surgery, weight loss, and other medical cosmetic services; a fertility center; and a clinic for bariatric surgery. In addition, it offers a cardiology center for diagnosing and treating cardiac diseases; the stroke unit to diagnose and treat stroke; and a unit that takes care for patients suffering from diabetes and diabetic foot, as well as the long-term care and rehabilitation services. Further, the company is involved in the wholesale of medical equipment and drugs. Mouwasat Medical Services Company was founded in 1974 and is based in Dammam, the Kingdom of Saudi Arabia.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Mouwasat Medical Services Company has the following listings and related stock indices.
Stock: Tadawul: 4002 wb_incandescent